Overview
The fund is passively managed and is distinguished by broad diversification, low tracking errors, and low-cost management. The investment objective is to replicate the reference index as closely as possible and to minimize performance deviations from the benchmark. The MSCI Europe (NR) Index captures large and mid cap representation across 15 Developed Markets (DM) countries in Europe.
The investment objective is to replicate the reference index as closely as possible and to minimize performance deviations from the benchmark.
The MSCI Europe (NR) Index captures large and mid cap representation across 15 Developed Markets (DM) countries in Europe.
The fund may enter into securities lending.
The exchange rate risk between EUR and USD is not hedged.
Benefits
Provides access to the performance of the index with a single transaction.
Optimised risk/return profile thanks to a broad diversification across a range of sectors.
The fund offers a high degree of transparency and cost efficiency.
UCITS compliant fund.
Risks
Features
| Product category |
麻豆社 Equity Funds 麻豆社 Index Funds Equities |
| Product domicile |
Luxembourg
|
| Portfolio management |
麻豆社 Asset Management Switzerland AG, Zurich
|
| Fund management |
麻豆社 Asset Management (Europe) S.A., Luxembourg
|
| Custodian bank |
State Street Bank International GmbH, Luxembourg Branch
|
| Representative for products established under foreign law |
麻豆社 AG, Stockholm
|
| Day of inception |
October 4, 2021
|
| Currency of account |
USD
|
| Close of financial year |
December 31
|
| SFDR Classification |
Art.6
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.88% p.a.
|
| Total expense ratio (TER) |
0.85% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
MSCI Europe (NR) in USD
|
| Distribution Frequency |
n.a.
|
| ISIN |
LU2295702851
|
| Bloomberg Ticker |
CSLEECU LX
|
| Reuters Id |
59784141X.CHE
|
Performance and Prices
Percentage growth
as of May 27, 2026| USD(%) | EUR(%) | |
| YTD | ||
| 1M | ||
| 3M | ||
| 6M | ||
| 1Y | 18.66 | 15.75 |
| 2Y | ||
| 3Y | 56.30 | 43.92 |
| 5Y | - | - |
| ø p.a.5Y |
Current data
| Net asset value | 27.05.2026 | USD 1,556.60 |
| High - last 12 months | 27.02.2026 | USD 1,572.96 |
| Low - last 12 months | 19.06.2025 | USD 1,289.20 |
| Assets of the unit class in mn | 27.05.2026 | USD 29.06 |
| Total product assets in mn | 27.05.2026 | USD 224.25 |
Structures
By the 10 largest positions (in %, as of April 30, 2026)
|
|
|
| ASML Holding NV | 3.99 |
| HSBC Holdings PLC | 2.25 |
| AstraZeneca PLC | 2.09 |
| Roche Holding Ag | 2.05 |
| Novartis AG | 2.02 |
| Nestle SA | 1.87 |
| Shell PLC | 1.85 |
| Siemens AG | 1.62 |
| TotalEnergies SE | 1.31 |
| Banco Santander SA | 1.28 |
Fees
Distributions
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|
| Prospectus |
|
|
| Key Information Document |
|
|
| Past performance |
|
|
| Previous performance scenario |
|
|
| Statutes / Management regulations |
|
|
Document type
|
Document Language
|
| Annual report |
|
| Semi-annual report |
|